Teresa De Marco, MD

Director of Advanced Heart Failure and Pulmonary Hypertension
Medical Director of Heart Transplantation

Dr. Teresa De Marco is director of advanced heart failure and pulmonary hypertension and medical director of heart transplantation. She manages patients with advanced heart failure and pulmonary hypertension and is an expert in all treatment modalities for the conditions. She participates in multi-center studies evaluating state-of-the-art options for advanced disease states.

De Marco was certified in 2010 by the American Board of Internal Medicine in advanced heart failure and transplant cardiology. She earned a medical degree at the University of California at Irvine after graduating from the University of California at Berkeley. She completed an internship in internal medicine and a residency in internal medicine at UCSF Medical Center. She also completed fellowships in cardiology and heart transplantation. She is a professor of medicine and surgery at UCSF.

Clinics

Advanced Heart Failure Evaluation and Therapies Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday,
8 a.m. – 3 p.m.

Cardiovascular Genetics Program
400 Parnassus Avenue, Plaza Level, Room 94
San Francisco, CA 94143
Phone: (415) 353-2873
Fax: (415) 476-5355

Hours: Monday
noon – 4 p.m

Heart Transplant Program
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: Thursday, 8 a.m. – 5 p.m. (times vary depending on the number of doctors in clinic)

HHT Center of Excellence
185 Berry St., Suite 180, Lobby 6
San Francisco, CA 94107
Phone: (415) 353-8867
Fax: (415) 353-4503

Hours: Monday to Friday,
8 a.m. – 4:30 p.m.

Mechanical Circulatory Support
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143
Phone: (415) 353-4145
Fax: (415) 353-4166

Hours: 8 a.m. – 5 p.m.

Pulmonary Hypertension Clinic
400 Parnassus Ave., Plaza Level
San Francisco, CA 94143
Phone: (415) 353-9088
Fax: (415) 353-3889

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Conditions & Treatments

Board Certification

Advanced Heart Failure & Trans, American Board of Internal Medicine

Academic Title

Professor

More about Teresa De Marco

Additional Languages

Italian
Spanish

Education

UC Irvine School of Medicine 1982

Residencies

UCSF Medical Center, Internal Medicine 1985

Fellowships

UCSF Medical Center, Heart Failure 1987
UCSF Medical Center, Cardiovascular Disease 1989

Selected Research and Publications

  1. Inan OT, Baran Pouyan M, Javaid AQ, Dowling S, Etemadi M, Dorier A, Heller JA, Bicen AO, Roy S, De Marco T, Klein L. Novel Wearable Seismocardiography and Machine Learning Algorithms Can Assess Clinical Status of Heart Failure Patients. Circ Heart Fail. 2018 Jan; 11(1):e004313.
  2. Pittman S, Sethi P, Flavell RR, De Marco T, Hernandez Pampaloni M. Abnormal pulmonary 18F-florbetapir uptake in a patient evaluated for recurrent cardiac amyloidosis following orthotopic heart transplant. J Nucl Cardiol. 2017 Nov 03.
  3. Kallianos K, Brooks GC, Mukai K, Seguro de Carvalho F, Liu J, Naeger DM, De Marco T, Ordovas KG. Cardiac Magnetic Resonance Evaluation of Left Ventricular Myocardial Strain in Pulmonary Hypertension. Acad Radiol. 2018 Jan; 25(1):129-135.
  4. Psotka MA, McKee KY, Liu AY, Elia G, De Marco T. Palliative Care in Heart Failure: What Triggers Specialist Consultation? Prog Cardiovasc Dis. 2017 Sep - Oct; 60(2):215-225.
  5. Oudiz R, Agarwal M, Rischard F, De Marco T. An advanced protocol-driven transition from parenteral prostanoids to inhaled trepostinil in pulmonary arterial hypertension. Pulm Circ. 2016 Dec; 6(4):532-538.
  6. Gordon NA, O'Riordan DL, Dracup KA, De Marco T, Pantilat SZ. Let Us Talk About It: Heart Failure Patients' Preferences Toward Discussions about Prognosis, Advance Care Planning, and Spiritual Support. J Palliat Med. 2017 01; 20(1):79-83.
  7. Bertero T, Oldham WM, Cottrill KA, Pisano S, Vanderpool RR, Yu Q, Zhao J, Tai Y, Tang Y, Zhang YY, Rehman S, Sugahara M, Qi Z, Gorcsan J, Vargas SO, Saggar R, Saggar R, Wallace WD, Ross DJ, Haley KJ, Waxman AB, Parikh VN, De Marco T, Hsue PY, Morris A, Simon MA, Norris KA, Gaggioli C, Loscalzo J, Fessel J, Chan SY. Vascular stiffness mechanoactivates YAP/TAZ-dependent glutaminolysis to drive pulmonary hypertension. J Clin Invest. 2016 Sep 01; 126(9):3313-35.
  8. Pantilat SZ, O'Riordan DL, Rathfon MA, Dracup KA, De Marco T. Etiology of Pain and Its Association with Quality of Life among Patients with Heart Failure. J Palliat Med. 2016 Dec; 19(12):1254-1259.
  9. Svetlichnaya J, Janmohammed M, De Marco T. Special Situations in Pulmonary Hypertension: Pregnancy and Right Ventricular Failure. Cardiol Clin. 2016 Aug; 34(3):473-87.
  10. Badhwar N, James J, Hoffmayer KS, O'Connell JW, Green D, De Marco T, Botvinick EH. Utility of Equilibrium Radionuclide Angiogram-Derived Measures of Dyssynchrony to Predict Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy. J Nucl Med. 2016 Dec; 57(12):1880-1886.
  11. Barnett CF, De Marco T. Treatment of advanced group 2 PH. Prog Cardiovasc Dis. 2016 Jul-Aug; 59(1):78-86.
  12. Thomas RC, Singh A, Cowley P, Myagmar BE, Montgomery MD, Swigart PM, De Marco T, Baker AJ, Simpson PC. A Myocardial Slice Culture Model Reveals Alpha-1A-Adrenergic Receptor Signaling in the Human Heart. JACC Basic Transl Sci. 2016 Apr; 1(3):155-167.
  13. Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, De Marco T, Escarce JJ, Evangelista LS, Hanna B, Ganiats TG, Greenberg BH, Greenfield S, Kaplan SH, Kimchi A, Liu H, Lombardo D, Mangione CM, Sadeghi B, Sadeghi B, Sarrafzadeh M, Tong K, Fonarow GC. Effectiveness of Remote Patient Monitoring After Discharge of Hospitalized Patients With Heart Failure: The Better Effectiveness After Transition -- Heart Failure (BEAT-HF) Randomized Clinical Trial. JAMA Intern Med. 2016 Mar; 176(3):310-8.
  14. Parikh VN, Park J, Nikolic I, Channick R, Yu PB, De Marco T, Hsue PY, Chan SY. Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection. J Acquir Immune Defic Syndr. 2015 Nov 01; 70(3):236-41.
  15. Rosenkranz S, Gibbs JS, Wachter R, De Marco T, Vonk-Noordegraaf A, Vachiéry JL. Left ventricular heart failure and pulmonary hypertension. Eur Heart J. 2016 Mar 21; 37(12):942-54.
  16. Klein L, Greenberg BH, Konstam MA, Gregory D, Kociol RD, Johnson MR, de Marco T. Activities and Compensation of Advanced Heart Failure Specialists: Results of the Heart Failure Society of America (HFSA) Survey. J Card Fail. 2015 Nov; 21(11):924-9.
  17. Johnson CJ, Roberts JD, James JH, Hoffmayer KS, Badhwar N, Ku IA, Zhao S, Naeger DM, Rao RK, O'Connell JW, De Marco T, Botvinick EH, Scheinman MM. Comparison of radionuclide angiographic synchrony analysis to echocardiography and magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm. 2015 Jun; 12(6):1268-75.
  18. Howie-Esquivel J, Carroll M, Brinker E, Kao H, Pantilat S, Rago K, De Marco T. A Strategy to Reduce Heart Failure Readmissions and Inpatient Costs. Cardiol Res. 2015 Feb; 6(1):201-208.
  19. Naeger DM, Higgins C, De Marco T, Muzzarelli S, Ordovas KG. Low-intensity late gadolinium enhancement predominates in hypertrophic cardiomyopathy. Clin Imaging. 2015 May-Jun; 39(3):432-6.
  20. Deo RC, Musso G, Tasan M, Tang P, Poon A, Yuan C, Felix JF, Vasan RS, Beroukhim R, De Marco T, Kwok PY, MacRae CA, Roth FP. Prioritizing causal disease genes using unbiased genomic features. Genome Biol. 2014 Dec 03; 15(12):534.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.